Although promising, these in vivo findings leave open the question of whether local or systemic administration of the soluble forms of Sema3A, Sema3D, Sema3E, or Sema3F may recapitulate the tumor-suppressing effect of ectopically expressed molecules. Here, SEMA3F is linked to neoplasm.